Prelude Capital Management, LLC Alcon Inc Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$76.74 - $85.2 $605,708 - $672,483	-7,893 Reduced 39.4%	12,140 $935,000
Q2 2023 Aug 14, 2023	BUY	$69.16 - $82.11 $237,910 - $282,458	3,440 Added 20.73%	20,033 $1.64 Million
Q1 2023 May 15, 2023	BUY	$64.46 - $77.23 $553,453 - $663,096	8,586 Added 107.23%	16,593 $1.17 Million
Q4 2022 Feb 14, 2023	SELL	$56.51 - $71.71 $317,529 - $402,938	-5,619 Reduced 41.24%	8,007 $548,000
Q3 2022 Nov 14, 2022	SELL	$56.96 - $78.09 $195,714 - $268,317	-3,436 Reduced 20.14%	13,626 $793,000
Q2 2022 Aug 15, 2022	SELL	$64.25 - $81.25 $352,861 - $446,225	-5,492 Reduced 24.35%	17,062 $1.19 Million
Q1 2022 May 16, 2022	BUY	$71.65 - $87.13 $161,857 - $196,826	2,259 Added 11.13%	22,554 $1.79 Million
Q4 2021 Feb 14, 2022	SELL	$77.91 - $88.5 $409,650 - $465,333	-5,258 Reduced 20.58%	20,295 $1.77 Million
Q3 2021 Nov 15, 2021	BUY	$68.18 - $87.25 $1.74 Million - $2.23 Million	25,553 New	25,553 $2.06 Million
Q4 2019 Feb 14, 2020	SELL	$55.04 - $59.27 $58,342 - $62,826	-1,060 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$54.43 - $63.33 $57,695 - $67,129	1,060 New	1,060 $66,000

718

254M

2.51M

2.06M

Ticker ALC
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 490,087,008
Market Cap $46.5B
Description
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.